NCT01378923 Evaluation of Re-Entry Values and Mindfulness Program (REVAMP) With Jail Inmates Status UNKNOWN Phase PHASE1/PHASE2
NCT01376986 Activation of Young Men - Population-Based Randomised Controlled Trial Status COMPLETED Phase NA
NCT01375920 Antiglucocorticoid Augmentation of antiDepressants in Depression Status COMPLETED Phase PHASE3
NCT01375894 Body Movement Imitation and Perspective Perception Among Psychiatric Patients Status UNKNOWN Phase NA
NCT01372605 Trial of Collaborative Depression Care Management for HIV Patients Status COMPLETED Phase NA
NCT01370304 Repetitive Transcranial Magnetic Stimulation Compared or Associated With Venlafaxine for Depressive Disorder Status UNKNOWN Phase PHASE3
NCT01369095 Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression Status COMPLETED Phase PHASE2
NCT01367080 A Study to Compare the Pharmacokinetic Profiles of Etravil® Tablet 10mg and Etravil® Tablet 25mg Status COMPLETED Phase PHASE1
NCT01365377 Impact of Information Strategy Based on Booklet on Anxiety in Family in ICU Status UNKNOWN Phase NA
NCT01361555 Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression Status TERMINATED Phase PHASE2
NCT01360866 Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial) Status COMPLETED Phase PHASE3
NCT01360645 Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial) Status COMPLETED Phase PHASE3
NCT01360632 Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial) Status COMPLETED Phase PHASE3
NCT01359839 Effectiveness of a Relaxation-Response Based Cognitive Behavioral Therapy Group for Depressed Chinese Patients Status COMPLETED Phase NA
NCT01355523 The Effect of Melatonin on Depression, Anxiety, Cognitive Function and Sleep Disturbances in Breast Cancer Patients Status TERMINATED Phase PHASE2/PHASE3
NCT01352572 Effects of Antidepressant on Postsynaptic Signal Transduction in Serotonergic System of Depressed Patients Status UNKNOWN Phase NA
NCT01352559 Prediction of Antidepressant Response Using Pharmacogenetics and Peripheral Lymphocytic Phenotype Status UNKNOWN Phase NA
NCT01351454 Behavioral Depression Treatment for African American HIV-infected Substance Users Status COMPLETED Phase NA